Health & Environmental Research Online (HERO)


Print Feedback Export to File
7319384 
Journal Article 
Review 
3D Printing Technology in Customized Drug Delivery System: Current State of the Art, Prospective and the Challenges 
Khan, FA; Narasimhan, K; Swathi, CSV; Mustak, S; Mustafa, G; Ahmad, MZ; Akhter, S 
2018 
Yes 
Current Pharmaceutical Design
ISSN: 1381-6128
EISSN: 1873-4286 
Bentham Science Publishers B.V. 
24 
42 
5049-5061 
English 
30636582 
WOS:000461758200010 
BACKGROUND: 3D printing/Additive Manufacturing seems a pragmatic approach to realize the quest for a truly customized and personalized drug delivery. 3DP technology, with innovations in pharmaceutical development and an interdisciplinary approach to finding newer Drug Delivery Systems can usher a new era of treatments to various diseases. The true potential of this is yet to be realized, and the US-FDA is focusing on the regulatory science of 3D printed medical devices to help patients access this technology safely and effectively. The approval of the first 3D printed prescription medicine by FDA is a promising step in the translation of more research in this area.

METHODS: A web-search on PubMed, ScienceDirect, and Nature was performed with the keywords Customized 3D printing and Drug delivery, publications dealing with the aspects of drug delivery using 3D printing for personalized or customized delivery were further considered and analyzed and discussed.

RESULTS: We present the advantages offered by 3DP over conventional methods of formulation development and discuss the current state of 3DP in pharmaceutics and how it can be used to develop a truly customized drug delivery system, various 3DP technologies including Stereolithography (SLA), Selective Laser Sintering (SLS), Fused Deposition Modelling (FDM), Pressure Assisted Microsyringe (PAM) that have been used to develop pharmaceutical products have been discussed along with their limitations and also the regulatory considerations to help formulation scientists envisaging research in this area with the necessary information.

CONCLUSION: 3D printing has the potential to fabricate a customized drug delivery system. Presence of many drug formulation and the devices are already in the regulatory approval process indicating its success. 
3D printing; Customized drug delivery; Fused deposition modeling; Pressure assisted microsyringe; Selective laser sintering; Stereolithography; captopril; celecoxib; deflazacort; dexamethasone; dipyridamole; fenofibrate; fluorouracil; glipizide; guaifenesin; ibuprofen; insulin; isoniazid; lamivudine; levofloxacin; metformin; nifedipine; ofloxacin; paracetamol; prednisolone; progesterone; propranolol; riboflavin; rifampicin; ropinirole; salicylic acid; sodium phosphate cotransporter; tetracycline; theophylline; unindexed drug; vancomycin; drug; drug delivery system; drug formulation; excipient compatibility; Food and Drug Administration; fused deposition modelling; hot melt extrusion; human; personalized medicine; pressure assisted microsyringe; priority journal; Review; selective laser sintering; stereolithography; three dimensional printing; chemistry; drug delivery system; three dimensional printing; Drug Delivery Systems; Humans; Pharmaceutical Preparations; Printing, Three-Dimensional